Cliff Asness's TARS Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 25,919 shares of Tarsus Pharmaceuticals, Inc. (TARS) worth $2.12 M, representing 0.00% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 8 quarters.
Based on 13F filings, Cliff Asness has maintained this position in TARS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 37,344 shares. Largest reduction occurred in Q3 2025, reducing 16,473 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Tarsus Pharmaceuticals (TARS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tarsus Pharmaceuticals (TARS) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -11,176 | Reduce 30.13% | 25,919 | $81.88 |
| Q3 2025 | -16,473 | Reduce 30.75% | 37,095 | $59.43 |
| Q2 2025 | +37,344 | Add 230.18% | 53,568 | $40.51 |
| Q4 2024 | -3,696 | Reduce 18.55% | 16,224 | $55.37 |
| Q3 2024 | +12,427 | Add 165.85% | 19,920 | $32.89 |
| Q2 2024 | -2,702 | Reduce 26.50% | 7,493 | $27.18 |
| Q1 2024 | +10,195 | New Buy | 10,195 | $36.35 |
Cliff Asness's Tarsus Pharmaceuticals Investment FAQs
Cliff Asness first purchased Tarsus Pharmaceuticals, Inc. (TARS) in Q1 2024, acquiring 10,195 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Tarsus Pharmaceuticals, Inc. (TARS) for 8 quarters since Q1 2024.
Cliff Asness's largest addition to Tarsus Pharmaceuticals, Inc. (TARS) was in Q2 2025, adding 53,568 shares worth $2.17 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 25,919 shares of Tarsus Pharmaceuticals, Inc. (TARS), valued at approximately $2.12 M.
As of the Q4 2025 filing, Tarsus Pharmaceuticals, Inc. (TARS) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Tarsus Pharmaceuticals, Inc. (TARS) was 53,568 shares, as reported at the end of Q2 2025.